FDA Recalls Rizatriptan Benzoate Tablets for Manufacturing Impurity
Glenmark Pharmaceuticals is recalling Rizatriptan Benzoate 10mg tablets nationwide due to N-nitroso impurity levels exceeding FDA acceptable limits, affecting 13,296 cartons.
- Product
- RIZATRIPTAN BENZOATE — RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)
- Category
- Drug
- Distribution
- Distributed nationwide